ClinicalThought

Share

Program Content

Activities

  • Risk in HR+/HER2  EBC
    How Risk of Recurrence in HR-Positive/HER2-Negative Early Breast Cancer Impacts Therapeutic Choices
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2022

    Expires: November 13, 2023

    View Activity
  • Adj Abemaciclib in EBC: AE Management
    Optimizing Patient Outcomes and Quality of Life With Adjuvant Abemaciclib in HR+/HER2- Early Breast Cancer Through Adverse Event Management
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: January 31, 2023

    Expires: January 30, 2024

    View Activity
  • EBC: Strategies for Adherence
    Strategies to Maintain Adherence and Persistence to Oral Therapies in Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 13, 2023

    View Activity
  • Patient Communication in EBC
    Strategies for Optimizing Patient Communication: Focus on Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: May 30, 2023

    View Activity

Faculty

cover img faculity

Erika P. Hamilton, MD

Director, Breast Cancer Research Program
Sarah Cannon Research Institute
Tennessee Oncology
Nashville, Tennessee

cover img faculity

Julia LaBarbera, MSN, RN, AGACNP-BC

Nurse Practitioner
Division of Hematology/Oncology
Department of Medicine
University of California, Los Angeles
Santa Monica, California

cover img faculity

Reshma Mahtani, DO

Chief of Breast Medical Oncology
Medical Oncology
Miami Cancer Institute
Miami, Florida

cover img faculity

Joyce O'Shaughnessy, MD

Celebrating Women Chair in Breast Cancer Research
Director, Breast Cancer Research Program
Baylor University Medical Center
Medical Oncologist
Texas Oncology/ Baylor Charles A. Sammons Cancer Center
Dallas, Texas

Provided by

ProCE Banner

Supporters

Lilly